Reply to Williams et al

Affiliations

¹ Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
² Department of Medicine, McGovern Medical School, Houston, Texas, USA.
³ Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
⁴ Department of Medicine, Weill Cornell Medicine, Cornell University, New York, New York, USA.
⁵ Office of the Director, Center for Innovative Therapeutics and Diagnostics, Richmond, Virginia, USA.
⁶ Departments of Pharmacy and Medicine, Oregon Health and Science University Hospital and Clinics, Portland, Oregon, USA.
⁷ Department of Medicine, Duke University, Durham, North Carolina, USA.
⁸ Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
⁹ Department of Medical Affairs, Astellas Pharma Global Development Inc ., Northbrook, Illinois, USA.
¹⁰ Department of Medicine, UC Davis Health, Sacramento, California, USA.

M Hong Nguyen et al. Open Forum Infect Dis. 2024.

. 2024 Mar 8;11(3):ofae134.

doi: 10.1093/ofid/ofae134. eCollection 2024 Mar.

¹ Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
² Department of Medicine, McGovern Medical School, Houston, Texas, USA.
³ Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
⁴ Department of Medicine, Weill Cornell Medicine, Cornell University, New York, New York, USA.
⁵ Office of the Director, Center for Innovative Therapeutics and Diagnostics, Richmond, Virginia, USA.
⁶ Departments of Pharmacy and Medicine, Oregon Health and Science University Hospital and Clinics, Portland, Oregon, USA.
⁷ Department of Medicine, Duke University, Durham, North Carolina, USA.
⁸ Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
⁹ Department of Medical Affairs, Astellas Pharma Global Development Inc ., Northbrook, Illinois, USA.
¹⁰ Department of Medicine, UC Davis Health, Sacramento, California, USA.

No abstract available

References

1. Nguyen MH, Ostrosky-Zeichner L, Pappas PG, et al. Real-world use of mold-active triazole prophylaxis in the prevention of invasive fungal diseases: results from a subgroup analysis of a multicenter national registry. Open Forum Infect Dis 2023; 10:ofad424. - PMC - PubMed